Detalles de la búsqueda
1.
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice.
Int J Mol Sci
; 25(3)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339054
2.
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.
Immunol Cell Biol
; 101(7): 639-656, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37191045
3.
Purinergic Signalling in Physiology and Pathophysiology.
Int J Mol Sci
; 24(11)2023 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298149
4.
Animal Models for the Investigation of P2X7 Receptors.
Int J Mol Sci
; 24(9)2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37175933
5.
Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci
; 24(16)2023 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628721
6.
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.
Purinergic Signal
; 18(4): 451-467, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35478453
7.
The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.
Int J Mol Sci
; 23(10)2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628550
8.
Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model.
Immunology
; 164(2): 332-347, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021907
9.
P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model.
Clin Sci (Lond)
; 135(3): 495-513, 2021 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33463682
10.
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease.
Int J Mol Sci
; 22(15)2021 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34361109
11.
Loss of calpains-1 and -2 prevents repair of plasma membrane scrape injuries, but not small pores, and induces a severe muscular dystrophy.
Am J Physiol Cell Physiol
; 318(6): C1226-C1237, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32348180
12.
A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model.
Immunol Cell Biol
; 98(5): 397-410, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32181525
13.
Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease.
Clin Sci (Lond)
; 134(2): 207-223, 2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31934722
14.
Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73.
Purinergic Signal
; 16(3): 389-401, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32754836
15.
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice.
Purinergic Signal
; 16(1): 109-122, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170537
16.
P2Y2 and P2X4 Receptors Mediate Ca2+ Mobilization in DH82 Canine Macrophage Cells.
Int J Mol Sci
; 21(22)2020 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33202978
17.
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Immunol Cell Biol
; 97(6): 597-610, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30957314
18.
Nano-sunscreens - a double-edged sword in protecting consumers from harm: viewing Australian regulatory policies through the lenses of the European Union.
Crit Rev Toxicol
; 49(2): 122-139, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30950677
19.
Third meeting of the Australian and New Zealand Purine Club.
Purinergic Signal
; 19(4): 595-598, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594610
20.
James Saville Wiley (1936-2022): pioneer of purinergic research in Australia and abroad.
Purinergic Signal
; 19(4): 581-585, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458954